Literature DB >> 6643665

Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen.

T C Wu, S Y Koo.   

Abstract

Three commercial latex kits, IBL, MYCO-Immune, and IMMY, for the detection of cryptococcal antigen were compared in regard to sensitivity, specificity, and height of antigen titers. A total of 218 cerebrospinal fluid and 79 serum specimens from 239 patients were included. Twenty-two patients had culture-proven disseminated cryptococcosis. Both the IBL and MYCO-Immune kits had sensitivities of 100%, and the IMMY kit had sensitivities of 82.6 and 45.4% in CSF and serum specimens, respectively. There was one false-positive reaction in serum with the MYCO-Immune kit and one false-negative reaction on screen only with all three kits. Rheumatoid factor-containing sera were used to check the agglutination titers between matching anti-cryptococcal globulin reagents and normal globulin reagents. The finding that agglutination titer with anti-cryptococcal globulin reagents was fourfold higher than with normal globulin reagents in the MYCO-Immune kit is considered to be a cause for a false-positive reaction in serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643665      PMCID: PMC272854          DOI: 10.1128/jcm.18.5.1127-1130.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  DETECTION OF CRYPTOCOCCUS NEOFORMANS ANTIGEN IN BODY FLUIDS BY LATEX PARTICLE AGGLUTINATION.

Authors:  N BLOOMFIELD; M A GORDON; D F ELMENDORF
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

2.  Elimination of rheumatoid factor in the latex test for cryptococcosis.

Authors:  M A Gordon; E W Lapa
Journal:  Am J Clin Pathol       Date:  1974-04       Impact factor: 2.493

3.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Control for rheumatoid factor in the latex test for cryptococcosis.

Authors:  J E Bennett; J W Bailey
Journal:  Am J Clin Pathol       Date:  1971-09       Impact factor: 2.493

5.  Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors.

Authors:  L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

6.  Serum cryptococcal antigen determination in the presence of rheumatoid factor.

Authors:  R H Eng; A Person
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948

  6 in total
  17 in total

1.  Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

Authors:  Diane C McFadden; Oscar Zaragoza; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Cryptococcal cerebrospinal fluid shunt infection treated with fluconazole.

Authors:  D Eymard; F Lebel
Journal:  Can J Infect Dis       Date:  1993-07

3.  False-positive cryptococcal antigen test associated with use of BBL Port-a-Cul transport vials.

Authors:  Deborah A Wilson; Mary Sholtis; Sharon Parshall; Gerri S Hall; Gary W Procop
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

4.  False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis.

Authors:  B P Currie; L F Freundlich; M A Soto; A Casadevall
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid.

Authors:  U K Frank; S L Nishimura; N C Li; K Sugai; D M Yajko; W K Hadley; V L Ng
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 6.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

7.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

Authors:  F Dromer; J Charreire; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

Review 10.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.